The study highlighted a novel role of Jag1-ICD beyond the canonical Notch signalling in mediating the oncogenic KRAS pathway, which promotes malignant behaviour and confers chemoresistance to CRC cells. This evidence concerns the gene JAG1 and colorectal carcinoma.